Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

Kymera Therapeutics, Inc. · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
atopic-dermatitis
atopic dermatitis, kt621, stat6, stat6 degrader, targeted protein degrader, phase 1, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 896963
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.